Douglas Williamson
Corporate Officer/Principal bij The Royal College of Psychiatrists
Profiel
Douglas J.
Williamson is currently a Member at The Royal College of Psychiatrists.
Previously, he held positions as an Independent Director at Bright Minds Biosciences, Inc. from 2022 to 2023, Head-Early Phase Clinical Development Neuroscience at Eli Lilly & Co., Vice President & Global Head-Therapeutic at PAREXEL International Corp., Senior VP, Head-US Research & Development at H.
Lundbeck A, Chief Medical Officer at Avadel Pharmaceuticals Plc, and Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc. He obtained a doctorate degree from The University of Edinburgh.
Actieve functies van Douglas Williamson
| Bedrijven | Functie | Begin |
|---|---|---|
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Corporate Officer/Principal | - |
Eerdere bekende functies van Douglas Williamson
| Bedrijven | Functie | Einde |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 09-01-2023 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Opleiding van Douglas Williamson
| The University of Edinburgh | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Finance |
